Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 201, Issue 1, Pages 95-104Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20041912
Keywords
-
Categories
Funding
- NIAID NIH HHS [N01AI40023, R01 AI056268, R01 AI56268] Funding Source: Medline
Ask authors/readers for more resources
The large size of poxvirus genomes has stymied attempts to identify determinants recognized by CD8(+) T cells and greatly impeded development of mouse smallpox vaccination models. Here, we use a vaccinia virus (VACV) expression library containing each of the predicted 258 open reading frames to identify five peptide determinants that account for approximately half of the VACV-specific CD8(+) T cell response in C57BL/6 mice. We show that the primary immunodominance hierarchy is greatly affected by the route of VACV infection and the poxvirus strain used. Modified vaccinia virus ankara (MVA), a candidate replacement smallpox vaccine, failed to induce responses to two of the defined determinants. This could not be predicted by genomic comparison of viruses and is not due strictly to limited MVA replication in mice. Several determinants are immunogenic in cowpox and ectromelia (mousepox) virus infections, and immunization with the immunodominant determinant provided significant protection against lethal mousepox. These findings have important implications for understanding poxvirus immunity in animal models and bench-marking immune responses to poxvirus vaccines in humans.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available